AxoSim Speaks at 2024 ADC Toxicity Summit
AxoSim’s Director of Scientific Operations, Megan Terral, gave an oral presentation at the 2nd annual ADC Toxicity Summit titled “High-throughput […]
AxoSim Speaks at 2024 ADC Toxicity Summit Read more
AxoSim’s Director of Scientific Operations, Megan Terral, gave an oral presentation at the 2nd annual ADC Toxicity Summit titled “High-throughput […]
AxoSim Speaks at 2024 ADC Toxicity Summit Read more
Lise Harbom, Nicholas Coungeris, and Corey Rountree present at 2024 MPS World Summit Three AxoSim scientists presented at this year’s
MPS Features Three AxoSim Scientists at 2024 World Summit Read more
In 2023, Merck, Sanofi, and Fujifilm Cellular Dynamics collaborated as part of the IMI2 NeuroDerisk initiative to perform a comparative
The Society of Toxicology (SOT) brought together more than 5,000 people for its 63rd Annual Meeting and ToxExpo March 10
AxoSim Posters Featured at SOT 2024 Annual Meeting  Read more
January 12, 2021 AxoSim published a review paper with Springer Nature’s In Vitro Cellular & Developmental Biology – Animal on
December 10, 2020 We present a nontraditional fabrication technique for the realization of three-dimensional (3D) microelectrode arrays (MEAs) capable of
February 21. 2020 Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been
July 15, 2020 Organ-on-a-chip devices that mimic in vivo physiology have the potential to identify effects of chemical and drug exposure in
September 1, 2018 Growing concern suggests that some chemicals exert (developmental) neurotoxicity (DNT and NT) and are linked to the
Rotenone exerts developmental neurotoxicity in a human brain spheroid model Read more